Next generation inhibitors are advanced drugs that specifically target proteins and enzymes involved in cancer cell growth and survival. Unlike traditional chemotherapy, which affects both healthy and cancerous cells, these inhibitors aim to minimize damage to normal cells, thereby reducing side effects.
